Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer

NCT03981705 · clinicaltrials.gov ↗

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

TN ER-/PR-/HER2- Breast Cancer
Triple Negative Breast Cancer
HER2-positive Breast Cancer
ERany/PRany/HER2+ Breast Cancer

Interventions

RADIATION: Standard Trimodality Breast Imaging

Sponsor

Masonic Cancer Center, University of Minnesota